{
  "docId": "019de074-a86b-72ae-acf4-09eb2fd3a18a",
  "docSlug": "f1da613c1103b289ca26ebdf1a360ae4",
  "documentTitle": "Alkermes | Results Presentation Deck | 21 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 21,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-a86b-72ae-acf4-09eb2fd3a18a/16",
  "deckHref": "/decks/019de074-a86b-72ae-acf4-09eb2fd3a18a",
  "deckJsonHref": "/decks/019de074-a86b-72ae-acf4-09eb2fd3a18a.json",
  "deckAnchorHref": "/decks/019de074-a86b-72ae-acf4-09eb2fd3a18a#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.8,
        "x": 0.1,
        "y": 0.3
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af2bcaf4-c6d4-448b-990b-d60d59f3f9eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.07,
        "y": 0.52
      },
      "kind": "list",
      "text": "Submitted initial confidential draft Form 10 registration statement to SEC",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12777d99-77c4-4cfe-a41e-75d6b30ab2cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.55,
        "y": 0.52
      },
      "kind": "list",
      "text": "Advanced in process to identify and recruit senior leadership",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "998bca7a-a807-421b-87a9-7bf28b1fd6f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.3,
        "y": 0.52
      },
      "kind": "list",
      "text": "Requested IRS Private Letter Ruling to support separation of oncology business as tax-free distribution to shareholders",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8630396-36f4-4324-b67a-99497ca7fae3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.78,
        "y": 0.52
      },
      "kind": "list",
      "text": "New company to be known as Mural Oncology plc",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b370d5d7-ce6b-4259-8ccd-ee71fd7c5154",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.78
      },
      "kind": "paragraph",
      "text": "Separation on track for completion in H2 2023, subject to various customary conditions, including final approval from Alkermes’ Board of Directors",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61456aa3-31d4-4240-bf6d-fdf7a45796fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "Oncology Business Separation Updates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ead514e-6f89-44f2-9985-112f8d357221",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "2ec13012-4f5e-4fa3-887a-4ffaa7efc103",
      "evidence": "list/bullet: Requested IRS Private Letter Ruling to support separation of oncology business as tax-free distribution to shareholders",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 17,
      "from": 15,
      "beatId": "1abdc999-2841-4c49-9bdd-97e3feb9fb1c",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The deck provides clear priorities, oncology business separation updates, and clinical development plan, satisfying the need for updates.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 17,
      "from": 15,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "bb2f89f1-4583-4873-95d9-04c800aded6b",
      "evidence": "The deck emphasizes the need for clear priorities and updates on the oncology business separation.",
      "position": 0,
      "objective": "Highlighting the importance of clear priorities and oncology business separation updates",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}